Weekly weigh-ins are necessary for re-dosing, and monthly InBody 770 scans are part of the maintenance plan
People who are otherwise healthy may be less willing to accept these potentially serious adverse events. The findings of the US study have been published in the Journal of the American Medical Association, and researchers now hope regulatory agencies and drugmakers will consider updating warning labels on their products
Authors contributions Study concept and design (TOA, BOE, CNE, CON), acquisition of data (TOA), drafting of the manuscript (TOA, CON), critical revision of the manuscript for important intellectual content (TOA, BOE, CNE, CON), administrative, technical, or material support (BOE, CNE), and study supervision (CON)

Other notable side effects include: Injection site reactions such as redness, itching, or bruising at the injection site Fatigue some patients report feeling more tired than usual Hypoglycaemia low blood sugar is uncommon with Ozempic alone but may occur when used alongside insulin or sulfonylureas (doses of these medications may need adjustment by your prescriber) Important safety warnings from the UK SmPC include: Acute pancreatitis seek immediate medical attention for severe, persistent abdominal pain, with or without vomiting Gallbladder disease including gallstones and inflammation of the gallbladder Diabetic retinopathy complications particularly in patients with pre-existing retinopathy when blood glucose improves rapidly Dehydration and kidney problems severe gastrointestinal side effects may lead to dehydration and acute kidney injury Hypersensitivity reactions including rash, itching and rarely, anaphylactic reactions It is important to note that swollen lymph nodes are not listed among the recognised side effects of Ozempic in the UK SmPC or patient information leaflet
